David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.1% |
| 2 | Technology | 16.45% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Communication Services | 9.04% |
| 5 | Healthcare | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXDR
2026
Nextdoor Holdings
NXDR
$901M
| $3.33M | ﹤0.01% |
+329,617
| New | +$3.3M |
|
|
APHA
2027
DELISTED
Aphria Inc. Common Shares
APHA
| $3.32M | ﹤0.01% |
180,903
+108,337
| +149% | +$1.76M |
|
2028
Allstate
ALL
$65.2B
| $3.32M | ﹤0.01% |
28,906
-255,137
| -90% | -$28.1M |
|
|
TMX
2029
DELISTED
Terminix Global Holdings, Inc.
TMX
| $3.32M | ﹤0.01% |
69,603
-524,855
| -88% | -$25.9M |
|
2030
Allegiant Air
ALGT
$2.24B
| $3.31M | ﹤0.01% |
13,561
-64,994
| -83% | -$14.4M |
|
2031
Bio-Rad Laboratories Class A
BIO
$10.5B
| $3.31M | ﹤0.01% |
5,792
-2,122
| -27% | -$1.26M |
|
2032
PUT
Cardinal Health
CAH
$54.7B
| $3.31M | ﹤0.01% |
54,400
-39,700
| -42% | -$2.19M |
|
2033
PUT
KLA
KLAC
$239B
| $3.3M | ﹤0.01% |
100,000
-22,000
| -18% | -$663K |
|
2034
Arcturus Therapeutics
ARCT
$447M
| $3.3M | ﹤0.01% |
+79,938
| New | +$4.77M |
|
2035
Kemper
KMPR
$1.62B
| $3.3M | ﹤0.01% |
+41,369
| New | +$3.19M |
|
2036
PUT
United Rentals
URI
$65.2B
| $3.29M | ﹤0.01% |
10,000
-46,100
| -82% | -$13.1M |
|
2037
Par Pacific Holdings
PARR
$3.75B
| $3.29M | ﹤0.01% |
232,984
-48,567
| -17% | -$755K |
|
|
SGI
2038
PUT
Somnigroup International
SGI
$13.1B
| $3.29M | ﹤0.01% |
90,000
| – | – |
|
|
IVC
2039
DELISTED
Invacare Corporation
IVC
| $3.28M | ﹤0.01% |
409,314
-6,581
| -2% | -$61.3K |
|
|
THCA
2040
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
| $3.28M | ﹤0.01% |
325,000
| – | – |
|
2041
Standard Motor Products
SMP
$827M
| $3.28M | ﹤0.01% |
78,768
+37,795
| +92% | +$1.61M |
|
2042
CALL
Generac Holdings
GNRC
$11.9B
| $3.27M | ﹤0.01% |
+10,000
| New | +$2.95M |
|
|
SRNE
2043
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.27M | ﹤0.01% |
395,305
+62,967
| +19% | +$665K |
|
|
EBIX
2044
DELISTED
Ebix Inc
EBIX
| $3.27M | ﹤0.01% |
102,027
-120,386
| -54% | -$4.64M |
|
2045
Daktronics
DAKT
$953M
| $3.26M | ﹤0.01% |
519,521
+26,035
| +5% | +$147K |
|
2046
Gibraltar Industries
ROCK
$1.37B
| $3.26M | ﹤0.01% |
35,591
-87,496
| -71% | -$8.03M |
|
|
TGH
2047
DELISTED
Textainer Group Holdings limited
TGH
| $3.26M | ﹤0.01% |
113,695
+83,357
| +275% | +$1.93M |
|
2048
Columbia Banking Systems
COLB
$8.67B
| $3.25M | ﹤0.01% |
75,504
+52,864
| +233% | +$2.3M |
|
2049
Radware
RDWR
$1.24B
| $3.25M | ﹤0.01% |
124,647
-79,697
| -39% | -$2.18M |
|
|
BAND
2050
Bandwidth Inc
BAND
$1.63B
| $3.24M | ﹤0.01% |
25,597
-81,815
| -76% | -$12.7M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $10.4B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.